Webinar on

Obesity, Human Metabolism and Diabetes healthcare


Theme: New emerging challenges in Diabetes, Metabolism, Obesity and their preventions

We are delighted to announce the upcoming “Webinar on Obesity, Human Metabolism and Diabetes healthcare” scheduled to be held on August 24-25, 2020 in Berlin, Germany. The theme is “New emerging challenges in Diabetes, Metabolism, Obesity and their preventions”. Diabetes Care Congress 2020 creates a platform to share and gain knowledge by focusing on the topics Diabetes types & Complications, Endocrinology & Endocrine system, Epidemiology, Clinical Practice in Diabetes, Diabetic Ketoacidosis & Hyperglycaemia- Hypoglycaemia, Pathophysiology, Gestational Diabetes, Paediatric diabetes, Diabetes Traditional Medicine & Chinese Traditional Medicine, Pre-Diabetes, Cardiovascular Diseases, Human Metabolism, Metabolic Syndrome & Metabolic disorders, Obesity, Weight Management & Physical Activity, Nutrition, Dietetics and Eating Disorders, Nephrology & Neuropathy, Retinopathy, Wound Care and Management, Glycaemic Management. It will bring together world-class Directors, Professors, Scientists and Researchers to discuss the multidisciplinary field with research and interests covering all aspects of recent Diabetes Healthcare, Metabolism & Obesity. The Diabetes care Congress shall include prompt keynote presentations, special sessions, workshops, symposiums, oral talks, poster presentations and exhibitions.


9th World Congress on Obesity, Human Metabolism and Diabetes healthcare is organizing an outstanding Scientific Exhibition/Program and anticipates the world’s leading specialists involved in. Diabetes care 2020 organizing committee anticipates over 300 participants to attend this premier event. To enhance your campaign or increase the longevity of your products and services exposure, Diabetes Care conference provides a platform to showcase your new products and services. Your organization will benefit with excellent exposure to the leaders in Diabetes & Endocrinology. Diabetes Care 2020 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.

Meetings International specializes in planning and executing successful conferences across the globe for the dissemination of knowledge among eminent scientists, researchers, institutions and associations. Over the years, we’ve always strived to increase the quality and standard in the scientific meetings industry and have successfully achieved our goals in offering the best academic and corporate delegations. We also strive to bring different aspects of the industry together as all our events are great venues for successful product launches and exhibitions.

Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator. Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world.

Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.

For further queries, connect our conference manager at diabetescare@annualmeetings.net; sponsor@meetingsint.com

You can also connect us via WhatsApp: +65 3158 1626 / + 44 122980269

Google Analytics Metrics of Diabetes Care 2020:

  • The visitor’s traffic is the benchmark for the success of conference and Diabetes Care  2020 is constantly attracting viewers across the world.
  • According to the Google Analytics, more than 900+ monthly audiences are visiting to our conference websites for submitting abstracts, brochure downloads, registration, exhibition and sponsorship queries.
  • Readers from the major countries including United States, Japan, United Kingdom, European Union, Asia-Pacific and Middle East visit our conference domain to participate and present their latest research.

Google Analytics Metrics of Meetings International:

  • 437,380 + Users
  • 1,606,987 + Page views
  • 644,430 Sessions at the rate of 1.47 per user

Meetings International has so far received 644,430 Sessions which confirm the outstanding pool of new users and visitors. Meetings International works on Open Access publishing model, hence they are the best choice for the scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication and circulation of the published material worldwide with in no time while enhancing the visibility of the authors and conferring credibility to scholars and readers.

The promotion of the individual author contributions is taken care of and hence the authors enjoy the reputation among global audience. Meetings International  values the contributions by the authors and takes adequate measures in propagating and promoting their outcomes by permanently archiving as well.

Meetings International has taken an initiative to felicitate attendees with awards to recognise, celebrate and encourage achievement in its various conferences and events. These awards have different committees, nominating procedures and submission deadlines. We salute and acknowledge attainment within an industry that is continuously evolving and re-drawing the boundaries of best practice. These awards represent the pinnacle of professional achievement for event professionals. They recognize Best Eminent Presentation Award, Outstanding Oral Presentation Award, Best Organising Committee Member Award, Outstanding Future Scientist Presentation Award & Best Poster Award. We invite all enthusiastic researchers from all around the world join us for the Diabetes Care conference scheduled during August 24-25, Berlin, Germany.

  • Best Eminent Presentation Award: Diabetes Care will honour the Keynote Speakers who have made significant contributions to the field of Daibetes Healthcare but also makes a difference by his presence during the conference. Recipients of the award are considered to have advanced the field through research or service.



  • Outstanding Oral Presentation Award: There will be a number of technical sessions in the conference under different themes. These awards are provided to the presentations that have been selected to be the best in the particular session. Diabetes Care perceives the individuals who have made significant and imaginative walks in education system. This award will be provided for the most outstanding presentation of the entire conference.


  • Best Organizing Committee Member Award: Diabetes Care will honour the individual who has demonstrated exemplary support and guidance throughout the conference.


  • Outstanding Future Researcher Presentation Award: The Future Researcher Presentation Award will be given to the most outstanding presentation presented by a participant who has registered under the student category. Undergraduates, Master students, and Ph.D. students will be considered under this category. This award recognizes individuals in the early stages of their careers who have already made outstanding research, teaching, and/or service contributions to the field of information systems.


  • Best Poster Award: There will be a poster session at the Diabetes Care and this award is dedicated to the poster presenters in the conference. The best poster presentation will be selected among all the researchers in the session. Recipients of the award are considered to be the Best Poster Presenter of the conference.


The awards given for our Daibetes conferences (conference subject) recognise the wide range of responsibilities and dedication of Diabetes and Diabetes & Endocrinology professionals who promote the highest standards of care across the whole health service. Diabetes Care events make a huge contribution to maintaining and protecting the health and well-being of people across the globe.


  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners will be formally announced during the closing ceremony.
  • The winners of the Poster Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.


  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference
  • Each poster should be approximately 1x1 M long. The title, contents and the author’s information should be clearly visible from a distance of 1-2 feet.


Meetings International is announcing Young Scientist Awards through 9th World Congress on Obesity, Human Metabolism and Diabetes healthcare (Diabetes Care 2020) which is scheduled at Berlin, Germany during August 24-25, 2020. This Diabetes Care conference focuses on “New Emerging Challenges in Diabetes, Metabolism, Obesity and their Preventions”.

Diabetes Care 2020 and upcoming conferences will recognise participants who have significantly added value to the scientific community of Diabetes & Endocrinology and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Diabetes Care 2020 focuses mainly on Obesity, Diabetes and Metabolic Syndrome, Diabetes Wound Care, Endocrinology, Cardio metabolic Disease, Pathophysiology, Diabetic Nephropathy, Diabetes Eye Diseases. Diabetes Care conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.


Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

  • Acknowledgement as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee


  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.


  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of Diabetes Care Conference.


Session 1: Diabetes Mellitus & Complications

Diabetes mellitus is a very common disorder caused by high levels of sugar in the bloodstream. It affects a large number of people, with many more people remaining undiagnosed. Diabetes mellitus is linked with an increased risk of heart attacks, strokes, poor blood circulation to the legs and damage to the eyes, feet and kidneys. Early diagnosis and strict control of blood sugar, blood pressure and cholesterol levels can help to prevent or delay these complications associated with diabetes. Maintaining a healthy lifestyle (regular exercise, eating healthily and maintaining a healthy weight) is important in reducing the risk of developing type 2 diabetes. Insulin is a hormone produced by the beta cells within the pancreas in response to the intake of food. The role of insulin is to lower blood sugar (glucose) levels by allowing cells in the muscle, liver and fat to take up sugar from the bloodstream that has been absorbed from food, and store it away as energy. In type1 diabetes (previously called insulin-dependent diabetes mellitus), the insulin-producing cells are destroyed and the body is not able to produce insulin naturally. This means that sugar is not stored away but is constantly released from energy stores giving rise to high sugar levels in the blood. This in turn causes dehydration and thirst (because the high glucose ‘spills over’ into the urine and pulls water out of the body at the same time). In ‘type 2 diabetes’ (previously called non-insulin-dependent diabetes mellitus), which accounts for 90% of all diabetes, the beta cells do not stop making insulin completely, but the insulin produced does not work properly so it struggles to store the sugar found in the blood. As a consequence, the pancreas has to produce more insulin to compensate for this reduction in insulin function. This is called insulin resistance and is commonly linked to obesity. This type of diabetes is seen more commonly over the age of 40 years but can occur at any age. 

Session 2: Endocrinology & Endocrine system

Endocrinology is the field of hormone-related diseases. An endocrinologist can diagnose and treat hormone problems and the complications that arise from them. Hormones regulate metabolism, respiration, growth, reproduction, sensory perception, and movement. Hormone imbalances are the underlying reason for a wide range of medical conditions. Endocrinology focuses both on the hormones and the many glands and tissues that produce them. Humans have over 50 different hormones. They can exist in very small amounts and still have a significant impact on bodily function and development. Here are some key points about endocrinology. More information is in the main article. Endocrinology involves a wide range of systems within the human body. The endocrine tissues include the adrenal gland, hypothalamus, ovaries, and testes. There are three broad groups of endocrine disorders. Polycystic ovary syndrome is the most common endocrine disorder in women. The human endocrine system consists of a number of glands, which release hormones to control many different functions. When the hormones leave the glands, they enter the bloodstream and are transported to organs and tissues in every part of the body.

Session 3:  Recent Advancements in Diabetes Research & Clinical Practice

The growing human and economic toll of diabetes has caused consternation worldwide. Not only is the number of people affected increasing at an alarming rate, but onset of the major forms of the disease occurs at ever younger ages. We now know that the reach of diabetes extends far beyond the classic acute metabolic and chronic vascular complications to increased risk of an ever-increasing array of conditions including Alzheimer disease, cancer, liver failure, bone fractures, depression, and hearing loss. Hybrid Closed-loop systems have harnessed the data gathered with CGM use to aid in basal insulin dosing And hypoglycaemia   prevention. As technology continues to progress, patients will likely have to enter less and less information into their pump system manually. In the future, we will likely see a system that requires no manual patient input and allows users to eat throughout the day without counting Carbohydrates or entering in any blood sugars. As technology continues to advance, endocrinologists and diabetes providers need to stay current to better guide their patients in optimal use of emerging Management tools.

Session 4:  Diabetic Ketoacidosis & Hyperglycaemia- Hypoglycaemia

Diabetic ketoacidosis (DKA) is a build-up of acids in our blood. It can happen when your blood sugar is too high for too long. It could be life-threatening, but it usually takes many hours to become that serious. You can treat it and prevent it, too. It usually happens because your body doesn't have enough insulin. Your cells can't use the sugar in your blood for energy, so they use fat for fuel instead. Burning fat makes acids called ketones and, if the process goes on for a while, they could build up in your blood. That excess can change the chemical balance of your blood and throw off your entire system. People with type 1 diabetes are at risk for ketoacidosis, since their bodies don't make any insulin. Your ketones can also go up when you miss a meal, you're sick or stressed, or you have an insulin reaction. DKA can happen to people with type 2 diabetes, but it's rare. If you have type 2, especially when you're older, you're more likely to have a condition with some similar symptoms called HHNS (hyperosmolar hyperglycaemic nonketotic syndrome). It can lead to severe dehydration.


This occurs when the level of insulin in the blood is greater than glucose, lowering glucose to levels below 70 mg/dL (3.9 mmol/L). Some call this an “insulin reaction” because it often occurs when too much insulin is given to a patient. It may also occur with excessive physical activity without eating enough carbohydrates. Because sulfonylureas stimulate insulin release, reminding patients to eat regular meals may reduce hypoglycemic excursions. If someone consistently has high blood glucose levels greater than 200 mg/dL (11.1 mmol/L), hypoglycemic symptoms may be experienced when blood glucose lowers into a normal range (between 80 and 150 mg/dL; 4.4 and 8.3 mmol/L, respectively). A small (15 g) carbohydrate and protein snack will help abate these symptoms because it will increase the blood glucose slightly and the protein will maintain the blood glucose for a longer period of time. It is important to communicate the need to attain normal glucose levels at a slower progress to avoid these symptoms from occurring. The brain is at risk when glucose dips below 70 mg/dL (3.9 mmol/L).

  • Shaking, sweating, or clammy skin
  • Sudden nervousness, confusion, headache, or irritability
  • Rapid heart rate
  • Dizziness, weakness, or fatigue
  • Hunger and nausea


All forms of diabetes cause hyperglycaemia if they are not properly treated. During an episode of hyperglycaemia the insides of blood vessels becomes irritated and damaged when glucose is elevated, similar to sandpaper or chards of glass rubbing an interior vessel wall. Most complications of diabetes arise when the smaller blood vessels of the body become even smaller from this damage. Frequent problems occur in the brain, eyes, heart, kidneys, and peripheral nerves, which have smaller vascularity and are affected first. Resulting stroke, blindness, myocardial infarction, renal disease, and peripheral neuropathy become chronic conditions to manage.

  • Polyuria
  • Polydipsia
  • Polyphagia
  • Weight loss
  • Random glucose greater than 200 mg/dL (11.1 mmol/L)
  • Frequent infection
  • Blurry vision

Session 5:  Pathophysiology: Gestational Diabetes, Paediatric diabetes

Pathophysiology develops when the body's immune system destroys pancreatic beta cells, the only cells in the body that make the hormone insulin, which regulates blood glucose. Only 5% of people with diabetes have this form of the disease. To survive, people with type 1 diabetes must have insulin delivered by injection or a pump. (i) Pathophysiology of type 1 diabetes, in this condition the immune system attacks and destroys the insulin producing beta cells of the pancreas. There is beta cell deficiency leading to complete insulin deficiency. Thus is it termed an autoimmune disease where there are anti insulin or anti-islet cell antibodies present in blood. These cause lymphocytic infiltration and destruction of the pancreas islets. The destruction may take time but the onset of the disease is rapid and may occur over a few days to weeks. (ii) Pathophysiology of type 2 diabetes, this condition is caused by a relative deficiency of insulin and not an absolute deficiency. This means that the body is unable to produce adequate insulin to meet the needs. There is Beta cell deficiency coupled with peripheral insulin resistance. Peripheral insulin resistance means that although blood levels of insulin are high there is no hypoglycaemia or low blood sugar. This may be due to changes in the insulin receptors that bring about the actions of the insulin.

Gestational Diabetes

Gestational diabetes is a temporary (in most cases) form of diabetes in which the body does not produce adequate amounts of insulin to regulate sugar during pregnancy. It may also be called glucose intolerance or carbohydrate intolerance. In gestational diabetes, blood sugar usually returns to normal soon after delivery. But if you've had gestational diabetes, you're at risk for type 2 diabetes. You'll continue working with your health care team to monitor and manage your blood sugar.

Paediatric diabetes

Paediatric diabetes in children is a condition in which your child's body no longer produces an important hormone (insulin). Your child needs insulin to survive, so you'll have to replace the missing insulin. Type 1 diabetes in children used to be known as juvenile diabetes or insulin-dependent diabetes. The diagnosis of type 1 diabetes in children can be overwhelming at first. Suddenly you and your child — depending on his or her age — must learn how to give injections, count carbohydrates and monitor blood sugar. Type 1 diabetes in children requires consistent care. But advances in blood sugar monitoring and insulin delivery have improved the daily management of the condition.

Session 6: Traditional Medicine & Chinese Traditional Medicine for Diabetes

Many common herbs and spices are claimed to have blood sugar lowering properties that make them useful for people with or at high risk of type 2 diabetes. A number of clinical studies have been carried out in recent years that show potential links between herbal therapies and improved blood glucose control, which has led to an increase in people with diabetes using these more ‘natural’ ingredients to help manage their condition. Plant-based therapies that have been shown in some studies to have anti-diabetic properties include: Aloe vera, Bilberry extract, Bitter melon, Cinnamon, Fenugreek, Ginger, Okra.

Further Herbal Therapies

  • Allium
  • Bauhinia Forficata And Myrcia Uniflora
  • Coccinia Indica
  • Ficus Carica
  • Ginseng
  • Gymnema Sylvestre
  • Momordica Charantia
  • Ocimum Sanctum
  • Opuntia Streptacantha
  • Silibum Marianum
  • Trigonella Foenum Graecum

Session 7:  Pre-Diabetes and Cardiovascular Diseases

A diagnosis of prediabetes should be a warning for people to make lifestyle changes to prevent both full-blown diabetes and cardiovascular disease (CVD). We know that having diabetes increases the risk of developing cardiovascular disease, so in our study we wanted to determine what the absolute risk or probability of developing heart disease was for people who were only at a pre-diabetic level of blood sugar. Prediabetes is indicated by a fasting blood sugar level between100 and 125 mg/dL (5.6 to 6.9 mmol/L), while a fasting blood sugar level of less than 100 mg/dL (5.6 mmol/L) is considered normal. A level of 126 mg/dL (7 mmol/L) and higher is the diagnostic threshold for diabetes.

Session 8: Human Metabolism: Metabolic Syndrome & Metabolic disorders, Paediatric Metabolism Disorders

Digestion is characterized by the arrangement of life-managing substance changes inside the cells of living creatures. These compounds catalysed responses enable life forms to develop and imitate, keep up their structures, and react to their surroundings. The word digestion can likewise allude to every single concoction response that happens in living beings, including assimilation and the vehicle of substances into and between various cells, in which case the arrangement of responses inside the phones is called middle person digestion or moderate digestion. The term, 'Digestion,' alludes to the whole scope of biochemical procedures that occur inside a man or living creature. Digestion is something that comprises both,' Catabolism,' and, 'Anabolism;' which are the development and breakdown of substances. Digestion is a term used to allude especially to the breakdown of nourishment and its ensuing change into vitality the individual's body needs. In the field of Biology, Metabolism alludes to the majority of the body's substance forms, the assimilation of sustenance, and the disposal of waste.

Session 9: Obesity, Weight Management & Physical Activity

Obesity is an epidemic in Worldwide. This condition puts people at a higher risk for serious diseases, such as type 2 diabetes, heart disease, and cancer. Eating more calories than you burn in daily activity and exercise (on a long-term basis) causes obesity. Over time, these extra calories add up and cause you to gain weight. Weight Management: Eating well and maintaining a stable weight is particularly important for people with diabetes, so we figured that learning more about weight management was long overdue. Lowering waist measurement will help to improve your blood sugar control and reduce the risk of diabetes complications. Physical Activities is good for diabetes. Exercise helps control weight, lowers blood pressure, reduces harmful LDL cholesterol and triglycerides, raises healthy HDL cholesterol, strengthens muscles and bones, and reduces anxiety. Exercise can help regulate blood sugar and increase the body's sensitivity to insulin.

Session 10:  Nutrition, Dietetics and Eating Disorders

Nutrition is important to our healthy lifestyle when you have diabetes. Along with other benefits, following a healthy meal plan and being active can help you keep your blood glucose level, also called blood sugar, in your target range. To manage your blood glucose, you need to balance what you eat and drink with physical activity and diabetes medicine. Dietetics: They plan, monitor, and supervise the diet for patients (with medical conditions like diabetes, food allergies, gastro-intestinal disorders etc.) across hospitals, clinics, health centres, sports centres or their own private clinics. Dietitians are responsible for recommending proper as well as corrective food and eating habits, while taking into account the patient’s health, lifestyle, age, potential allergies and food preferences. Eating Disorders: The pressure to be thin can feel overbearing in our society. Eating disorders are common among women and girls in the general population. Research suggests that eating disorders are probably more common among women with diabetes than women who do not have diabetes. However, those with type 1 are twice as likely to suffer from disordered eating patterns. There is no data on eating disorders in men and boys with type 1 diabetes. However, disordered eating does occur among men and boys in the general population so don’t ignore the warning signs. Bulimia is the most common eating disorder in women with type 1 diabetes. Among women with type 2 diabetes, binge eating is more common.

Session 11:  Diabetes: Nephrology & Neuropathy

Diabetic nephropathy is a serious kidney-related complication of type 1 diabetes and type2 diabetes. About 25% of people with diabetes eventually develop kidney disease. Diabetic nephropathy affects your kidneys' ability to do their usual work of removing waste products and extra fluid from your body. The best way to prevent or delay diabetic nephropathy is by maintaining a healthy lifestyle and treating your diabetes and high blood pressure. Over many years, the condition slowly damages your kidneys' delicate filtering system. Early treatment may prevent or slow the disease's progress and reduce the chance of complications. Your kidney disease may progress to kidney failure, also called end-stage kidney disease. Kidney failure is a life-threatening condition. At this stage your treatment options are dialysis or a kidney transplant. Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes. High blood sugar (glucose) can injure nerves throughout your body. Diabetic neuropathy most often damages nerves in your legs and feet. Depending on the affected nerves, symptoms of diabetic neuropathy can range from pain and numbness in your legs and feet to problems with your digestive system, urinary tract, blood vessels and heart. Some people have mild symptoms. But for others, diabetic neuropathy can be quite painful and disabling.

Session 12: Diabetic Retinopathy

Diabetic retinopathy is the most common form of diabetic eye disease. Diabetic retinopathy usually only affects people who have had diabetes (diagnosed or undiagnosed) for a significant number of years. Retinopathy can affect all diabetics and becomes particularly dangerous, increasing the risk of blindness, if it is left untreated. The risk of developing diabetic retinopathy is known to increase with age as well with less well controlled blood sugar and blood pressure level. Non-proliferative diabetic retinopathy (NPDR): This is the milder form of diabetic retinopathy and is usually symptomless. Proliferative diabetic retinopathy (PDR): PDR is the most advanced stage of diabetic retinopathy and refers to the formation of new, abnormal blood vessels in the retina.

Session 13:  Diabetes Wound Care and Management

A diabetic foot ulcer is an open sore or wound that occurs in approximately 15 percent of patients with diabetes and is commonly located on the bottom of the foot. Of those who develop a foot ulcer, 6 percent will be hospitalized due to infection or other ulcer-related complication. Diabetes is the leading cause of non-traumatic lower extremity amputations in the United States, and approximately 14-24 percent of patients with diabetes who develop a foot ulcer will require an amputation. Foot ulceration precedes 85 percent of diabetes-related amputations. Research has shown, however, that development of a foot ulcer is preventable. Ulcers form due to a combination of factors, such as lack of feeling in the foot, poor circulation, foot deformities, irritation (such as friction or pressure), and trauma, as well as duration of diabetes. Patients who have diabetes for many years can develop neuropathy, a reduced or complete lack of ability to feel pain in the feet due to nerve damage caused by elevated blood glucose levels over time. The nerve damage often can occur without pain, and one may not even be aware of the problem. Your podiatrist can test feet for neuropathy with a simple, painless tool called a monofilament.

Session 14:  Epidemiology- Future Challenges in Diabetes

The application of epidemiology to the study of DM has provided valuable information on several aspects of this disease such as its natural history, prevalence, incidence, morbidity and mortality in diverse populations around the world. Identification of the cause of the disease and the possible preventive measures that could be instituted to arrest or delay the onset of this disease which has reached epidemic proportions in both the developed and the developing nations.  Given that the prevalence of diabetes is high at the population level, it imposes a financial burden on both our healthcare system and the individuals living with the disease. An attempt continues to be discussed; yet as the number of undiagnosed patients continues to grow, the prevalence and impact of the disease on patient quality of life and the overall cost of diabetes to healthcare is also important.

Session 15:  Glycaemic Management

One of the biggest challenges for health care providers today is addressing the continued needs and demands of individuals with chronic illnesses like diabetes. The importance of regular follow-up of diabetic patients with the health care provider is of great significance in averting any long term complications. Studies have reported that strict metabolic control can delay or prevent the progression of complications associated with diabetes. Results of large randomized trials involving patients with type 1 diabetes or newly recognized or established type 2 diabetes show that control of glycaemia delays the onset and slows the progression of micro vascular complications, including nephropathy, retinopathy, and neuropathy. The needs of diabetic patients are not only limited to adequate glycaemic control but also correspond with preventing complications; disability limitation and rehabilitation. Some of the Indian studies revealed very poor adherence to treatment regimens due to poor attitude towards the disease and poor health literacy among the general public.


Scope and importance

Diabetes can strike anyone, from any walk of life. And it does – in numbers that are dramatically increasing. Today, more than 30 million Americans have been diagnosed with diabetes. Worldwide, more than 422 million people have diabetes.  Diabetes is a serious condition that causes higher than normal blood sugar levels. Diabetes occurs when your body cannot make or effectively use its own insulin, a hormone made by special cells in the pancreas called islets (eye-lets). Insulin serves as a “key” to open your cells, to allow the sugar (glucose) from the food you eat to enter. Then, your body uses that glucose for energy. But with diabetes, several major things can go wrong to cause diabetes. Type 1 and type 2 diabetes are the most common forms of the disease, but there are also other kinds, such as gestational diabetes, which occurs during pregnancy, as well as other forms. Type 1 diabetes is the most severe form of the disease. About 10% of people who have diabetes have type1 diabetes, or insulin-dependent diabetes. Type 1 diabetes has also been called juvenile diabetes because it usually develops in children and teenagers. But people of all ages can develop type 1 diabetes.

The Diabetes Care Congress   2020 will focus on the latest and exciting innovations in all areas of Diabetes Health Care, Obesity and Metabolism, Endocrinology & Endocrine system, Epidemiology, Clinical Practice in Diabetes, Diabetic Ketoacidosis & Hyperglycaemia- Hypoglycaemia, Pathophysiology, Gestational Diabetes, Paediatric diabetes, Diabetes Traditional Medicine & Chinese Traditional Medicine, Pre-Diabetes, Cardiovascular Diseases, Human Metabolism, Metabolic Syndrome & Metabolic disorders, Obesity, Weight Management & Physical Activity, Nutrition, Dietetics and Eating Disorders, Nephrology & Neuropathy, Retinopathy, Wound Care and Management, Glycaemic Management  based research offering a unique opportunity for international explorers to assemble, network, talk and grasp new scientific innovations and ideas to prevent diabetes related ailments. To allocate advance researches, developments, druggists, scientists, technology challenges and improvement and alternative therapies, this meeting forms an excellent learning.

Diabetes in Europe

There are about 60 million people with diabetes in the European Region, or about 10.3% of men and 9.6% of women aged 25 years and over. Prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity.   The European diabetes devices market is expected to record a high CAGR of 7.51% during the forecast period (2019 - 2024), due to the growing prevalence of diabetes, growing geriatric population levels, unhealthy diet, and increasing levels of physical inactivity.

Diabetes in America

Diabetes was the seventh leading cause of death in the United States in 2015 based on the 79,535 death certificates in which diabetes was listed as the underlying cause of death. In 2015, diabetes was mentioned as a cause of death in a total of 252,806 certificates. Diabetes may be underreported as a cause of death. Studies have found that only about 35% to 40% of people with diabetes who died had diabetes listed anywhere on the death certificate and about 10% to 15% had it listed as the underlying cause of death.

Diabetes in Asia

The last three decades have witnessed an epidemic rise in the number of people with diabetes, especially type2 diabetes, and particularly in developing countries, where more than 80% of the people with diabetes live. The rise of type 2 diabetes in South Asia is estimated to be more than 150% between 2000 and 2035. Although aging, urbanization, and associated lifestyle changes are the major determinants for the rapid increase, an adverse intrauterine environment and the resulting epigenetic changes could also contribute in many developing countries. The International Diabetes Federation estimated that there were 382 million people with diabetes in 2013, a number surpassing its earlier predictions. More than 60% of the people with diabetes live in Asia, with almost one-half in China and India combined. The Western Pacific, the world’s most populous region, has more than 138.2 million people with diabetes, and the number may rise to 201.8 million by 2035.

Diabetes in Middle East and Africa

According to the International Diabetes Federation Atlas, 19.3 percent of adults aged 20 to 79 in the United Arab Emirates are diabetic. In Bahrain, the percentage rises to 19.6—and the statistic jumps to 20 percent for Kuwait, Qatar, and Saudi Arabia. According to the IDF Diabetes Atlas 8th Edition, approximately 38.7 million adults aged 20-79 years were living with diabetes in the Middle East and North Africa Region in 2017. Over two-thirds (67.3%) of adults with diabetes live in urban areas.

•    In Middle East & Africa (MEA), 15.51 million people are suffering from diabetes, and this population is expected to increase in the forecast period with a CAGR of 4.46%.

•    The Middle East & Africa diabetes drugs market (henceforth, referred to as the market studied) was valued at USD 2793.99 million in 2018, and it is expected to witness a CAGR of 6.48% during the forecast period 2019 - 2024, primarily due to the growing geriatric population.

Societies Associated with Diabetes Care

•    Endocrine Society Australia, Australia

•    American Diabetes Association, Virginia

•    European Society of Endocrinology, UK

•    British Society for Neuroendocrinology, London

•    International Neuroendocrine Federation, Canada

•    Association of British Clinical Diabetologist, UK

•    International Society of Endocrinology, Switzerland

•    Panhellenic Association of Endocrinologists, Greece

•    Spanish Society of Endocrinology and Nutrition, Spain

•    International Society of Psych neuroendocrinology, Italy

•    The American Association of Clinical Endocrinology, Florida

•    British Society for Paediatric Endocrinology and Diabetes, UK

•    British Association of Endocrine and Thyroid Surgeons, London

•    Royal Society of Medicine Endocrinology and Diabetes Section, London

•    Egyptian Association of Endocrinology, Diabetes and Atherosclerosis, Egypt

Global Universities Associated with Diabetes and Endocrinology

America Region

•    University of Alabama, USA

•    Mayo Medical School, USA

•    University of Arizona, USA

•    University of Arizona, USA

•    University of Arkansas, USA

•    California North state University, USA

•    Charles R. Drew University of Medicine and Science, USA

•    Keck School of Medicine of University of Southern California, USA

•    Loma Linda University, USA

•    Stanford University, USA

•    University of California, USA

•    George Washington University, USA

•    Florida International University, USA

•    University of Florida, USA

•    University of Calgary, Canada

•    University of Western Ontario, Canada

•    University of Waterloo, Canada

•    University of Montreal, Canada

•    McMaster University, Canada

•    University of Alberta, Canada

•    University of Sao Paulo, Brazil

•    Federal University of Rio De Janeiro, Brazil

•    Sao Paulo State University, Brazil

•    Federal University of Sao Paulo, Brazil

•    Federal University of Rio Grande Do Sul, Brazil

Asia Region

•    The University of Tokyo, Japan

•    National University of Singapore, Singapore

•    Kyoto University, Japan

•    University of Hong Kong, Hong Kong

•    Peking University, China

•    Seoul National University, South Korea

•    National Taiwan University, Taiwan

•    Osaka University, Japan

•    Nanyang Technological University, Singapore

•    Sungkyunkwan University, South Korea

•    Universiti Malaya, Malaysia

•    Indian Institute of Science, India

•    Universiti Kebangsaan Malaysia, Malaysia

•    University of Indonesia, Indonesia

•    Indian Institute of Technology Bombay, India

•    The Hong Kong University of Science and Technology (HKUST), Hong Kong

Middle East Region

•    Arabian Gulf University, Bahrain

•    Faculty of Medicine Zagazig University, Egypt

•    Benha University, Egypt

•    Fayoum Faculty of Medicine, Egypt

•    Bushehr University of Medical Sciences, Iran

•    Dezful University of Medical Sciences, Iran

•    Fasa Faculty of Medical Sciences, Iran

•    University of Kerabala, Iraq

•    University of Duhok, Iraq

•    Thi Qar University, Iraq

•    Minia Medical School, Egypt

•    Royal College of Surgeons in Ireland, Bahrain

•    Fatemiye University of Medical Sciences, Iran

•    Assiut Faculty of Medicine, Egypt

•    Suez Canal Faculty of Medicine, Egypt

Europe Region

•    LMU Munich, Germany

•    Technical University of Munich, Germany

•    University of Leuven, Belgium

•    University of Amsterdam, Netherlands

•    Humboldt University of Berlin, Germany

•    Leiden University, Netherlands

•    Utrecht University, Netherlands

•    Erasmus University Rotterdam, Netherlands

•    RWTH Aachen University, Germany

•    University of Groningen, Netherlands

•    University of Copenhagen, Denmark

•    University of Barcelona, Spain

•    University of Helsinki, Finland

Global Diabetes-endocrinology Research Centre’s

•    Joslin Diabetes Centre, USA

•    Diabetes Research Institute Foundation, USA

•    UCSF Diabetes Center, USA

•    Mayo Clinic, USA

•    Vanderbilt Diabetes Center, USA

•    Euradia, England

•    Dyna Health, Finland

•    Oxford Centre for Diabetes, Endocrinology and Metabolism, England

•    Lundberg Laboratory for Diabetes Research, Sweden

•    German Center for Diabetes Research, Sweden

•    Diabetes Complications Research Centre, Ireland

•    Dubai Diabetes Center, UAE

•    Diabetes Research Center, Japan

•    Imperial College London Diabetes Center, UAE

•    Hong Kong Institute of Diabetes and Obesity, China

•    Korea University Medical Center, South Korea

•    Tel Aviv Sourasky Medical Center, Israel

•    Sheba Medical Center, Israel

•    RAK Diabetes Center, UAE

Global Diabetes-Endocrinology Medicals/Hospitals

America Region

•    Cleveland Clinic, USA

•    Massachusetts General Hospital, USA

•    Johns Hopkins Hospital, USA

•    UCSF Medical Center, USA

•    New York-Presbyterian University Hospital of Columbia and Cornell, Canada

•    Yale-New Haven Hospital, USA

•    Northwestern Memorial Hospital, USA

•    UCLA Medical Center, Canada

•    University of Washington Medical Center, USA

•    Hospitals of the University of Pennsylvania-Penn Presbyterian, USA

•    Brigham and Women’s Hospital, USA

•    Florida Hospital Orlando, USA

•    Cedars-Sinai Medical Center, Canada

•    Barnes-Jewish Hospital/Washington University, USA

•    Beaumont Hospital, USA

•    Mount Sinai Hospital, USA

•    Froedtert Hospital and the Medical College of Wisconsin, USA

•    Lancaster General Hospital, USA

• University of Kansas Hospital, USA

•    Hospital Municipal Mendez, Argentina

Asian Region

•    Royal Prince Alfred Hospital, Australia

•    Royal Melbourne Hospital, Australia

•    Waikato Hospital, New Zealand

•    Faculty of Medicine Siriraj Hospital, Thailand

•    Prince Court Medical Centre, Malaysia

•    Fortis C-DOC Hospital, India

•    S. L Raheja Hospital, India

•    Apollo Hospitals, India

•    Indraprastha Apollo Hospital, India

•    Manipal Hospital, India

•    Tongji Hospital, China

•    Peking University People's Hospital, China

•    Peking University First Hospital, China

•    Bumrungrad International Hospital, Thailand

•    Bangkok Hospital Medical Center, Thailand

•    Gleneagles Hospital, Singapore

Middle East Region

•    King Faisal Specialist Hospital & Research Centre, Saudi Arabia

•    Riyadh Military Hospital, Saudi Arabia

•    Kbb Istanbul, Turkey

•    Ankara Saglik Müdürlügü, Turkey

•    Medicana Hospital Group, Turkey

•    American Hospital, UAE

•    Bezmi Alem Valide Sultan Vakif Gureba E A Hastanesi, Turkey

•    Hille Yaffe Medical Center, Israel

•    Erfan Hospital, Saudi Arabia

•    Ankara Numone Hospital, Turkey

•    Zulekha Hospital, UAE

•    Denizli Devlet Hastanesi, Turkey

•    King Fahad Medical Ci, Saudi Arabia

Europe Region

•    Swiss Prevention Clinic, Switzerland

•    Klinik Pyramide Am See, Switzerland

•    Health Centre, Switzerland

•    Clinique Générale-Beaulieu, Switzerland

•    Klinik Im Park, Switzerland

•    Klinik Hirslanden, Switzerland

•    Klinik Beau-Site, Switzerland

•    Hirslanden Clinique La Colline, Switzerland

•    Salem-Spital, Switzerland

•    Hirslanden Klinik, Switzerland

•    w. Goethe university hospital, Germany

Global Diabetes-Endocrinology Companies

•    Abbott Diabetes Care, USA

•    Accu-Chek, USA

•    Arkray USA, USA

•    Bayer, USA

•    LifeScan, USA

•    Animas, USA

•    Asante Solutions, USA

•    Abbot Laboratories, USA

•    Amylin Pharmaceuticals, USA

•    Aventis Pharmaceuticals, USA

•    Becton-Dickinson, USA

•    Bristol-Myers Squibb, USA

•    Novo Nordisk, USA

•    Pfizer, USA

•    SmithKline Beecham, USA

•    Takeda Pharmaceuticals, USA

•    Valeant, USA

•    Euradia, UK

•    MedTech Europe, Belgium

•    Cellnovo, France

•    Novo-Nordisk, Denmark

•    Acino, France

•    Thio Matrix -Austria

•    Biocrates, Austria






  • Diabetes Mellitus & Complications
  • Endocrinology & Endocrine system
  • Recent Advancements in Diabetes Research & Clinical Practice
  • Diabetic Ketoacidosis & Hyperglycaemia- Hypoglycaemia
  • Pathophysiology: Gestational Diabetes, Paediatric diabetes
  • Traditional Medicine & Chinese Traditional Medicine for Diabetes
  • Pre-Diabetes and Cardiovascular Diseases
  • Human Metabolism: Metabolic Syndrome & Metabolic disorders, Paediatric Metabolism Disorders
  • Obesity, Weight Management & Physical Activity
  • Nutrition, Dietetics and Eating Disorders
  • Diabetes: Nephrology & Neuropathy
  • Diabetic Retinopathy
  • Diabetes Wound Care and Management
  • Epidemiology- Future Challenges in Diabetes
  • Glycaemic Management